francesco paolo perelli

Low Burden Transthyretin Cardiac Amyloidosis on Cardiac Magnetic Resonance: Comprehensive Phenotyping and Distinction from Hypertrophic Phenocopies academic.oup.com/ehjimp/article…

Coronary microvascular dysfunction as an initial clue to the diagnosis of light-chain amyloidosis ow.ly/B9Kk50YgtCO #EHJCaseReports @Phiso_de @TJ_Yeo @aayshacader @BoldiKovacsMD @SukritiBanthiya @ANazmiCalik @O_Azizy_MD @saramoscatelli7 @EHJCREiC #CardioX

❤️ 🧲CMR T2 mapping predicts survival in AL amyloidosis—even after strong treatment response. Myocardial edema flags hidden risk beyond biomarkers. pdf 👉 journalofcmr.com/article/S1097-… Dr. Yining Wang explains below 👇 #WhyCMR

The authors present the largest series of #TTVR after T-TEER with electrosurgical leaflet modification in a subset of patients. At 30 days, TR severity was markedly reduced, and substantial symptom alleviation occurred. jacc.org/doi/10.1016/j.… #JACCINT #vhdTR #TEER @jtsaxon

Left Ventricular Ejection Fraction and Myocardial Fibrosis in Sudden Cardiac Death academic.oup.com/europace/artic…

Women with chronic coronary artery disease: long-term outcomes after percutaneous coronary intervention vs coronary artery bypass grafting academic.oup.com/eurheartj/arti…

Relative efficacy of tafamidis, acoramidis, patisiran and vutrisiran in patients with transthyretin cardiac amyloidosis: a network meta-analysis academic.oup.com/ehjopen/articl…

New in #JACCINT: 1-year results from the #CLASPIID trial show #MTEER benefits patients with degenerative MR across all cardiac damage stages 💪 Significant MR & #QoL improvements 🌟 low adverse events ⚡ and low mortality jacc.org/doi/10.1016/j.… #vhdMR #TEER @AbdullahAlabcha

2025 ACC Expert Consensus Decision Pathway on Evaluation & Management of Tricuspid Regurgitation @JACCJournals @ACCinTouch #TR #CardioX jacc.org/doi/10.1016/j.…

Atrial fibrillation ablation in hypertrophic obstructive cardiomyopathy – should we propose these patients to intervention? More on the potential outcomes in ow.ly/x9oM50X7Ify #EHJQCCO #AFib #HCM #PVI @cpgale3 @diogoasantosfer @m_piepoli

Today, I had the pleasure of discussing atrial fibrillation in patients with hypertrophic cardiomyopathy and cardiac amyloidosis. I would like to thank my mentor for this opportunity and for his continued support. @CrottiLia

Transthyretin amyloid cardiomyopathy: natural history and treatment response assessed by cardiovascular magnetic resonance academic.oup.com/eurheartj/arti…

Mitochondrial cardiomyopathies This review discusses comprehensive overview of the pathophysiology, clinical features, diagnostic approaches, and treatment options for mitochondrial #CMP academic.oup.com/eurheartj/adva… #CardioEd @ehj_ed @ESC_Journals

After 3 years of relentless hard work, passion, and dedication to #cvimaging and research in TR, our brilliant PhD student @michetomaselli has successfully defended his thesis! Michele, your fantastic journey has been inspiring for so many fellows and researchers that had the chance to work with you. The future is bright, and I’m honored to have been part of your path and to work with you daily. Congratulations—this is just the beginning! @lpbadano @ClementA25 @giorgio_oliver @Fraheilbron @Springhetti_P @fpperelli @GParati22 @TwittAuxologico @unimib #3DEcho #PhDSuccess #TricuspidRegurgitation #ProudMentor #FutureLeader

Therapeutic left-to-right shunting in heart failure. A State-of-the-Art review just published in #EHJ 👉 ow.ly/OyHA50V3n25 @RoccoMontone @ehj_ed #heartfailure

NEW ⚡️ Acute myocarditis: 2024 state of the art academic.oup.com/eurheartjsupp/…

In the EXPANDed studies, pts with moderate secondary mitral regurgitation (SMR) treated with M-TEER had improvements similar to subjects with severe SMR in #QoL and positive LV remodeling at 1 year. jacc.org/doi/10.1016/j.… #JACCHF #HeartFailure #TEER #HeartMonth @GilbertTangMD

Scpep1 inhibition attenuates myocardial infarction-induced dysfunction by improving mitochondrial bioenergetics. Discover more in #EHJ 👉 ow.ly/YhPG50V17Az @RoccoMontone @ehj_ed

In pts undergoing 99mTc PYP imaging for suspected ATTR-CM, very low hs-cTnT & NT-proBNP levels can effectively rule out the diagnosis, although in a small subset of pts. jacc.org/doi/10.1016/j.… #JACCCardioOnc #CardioOnc #ATTR #hscTnT #NTproBNP #Amyloidosis @LauraDemichieli

T-TEER improves 1-year survival in patients with intermediate-stage tricuspid regurgitation💡 No benefit seen in early or advanced stages 🚑 Timing of intervention is crucial for optimal outcomes! 🫀 jacc.org/doi/10.1016/j.… #TEER #Cardiology #vhdTR @PhilippLurz